CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) shares dropped 1.6% on Thursday . The stock traded as low as C$4.98 and last traded at C$5.01. Approximately 17,076 shares were traded during trading, an increase of 153% from the average daily volume of 6,748 shares. The stock had previously closed at C$5.09.
CSPC Pharmaceutical Group Price Performance
The stock’s fifty day simple moving average is C$4.17 and its 200-day simple moving average is C$4.56.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
See Also
- Five stocks we like better than CSPC Pharmaceutical Group
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
